FRAIZERON Canadian Trademark Information

Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, ...

Perfect for these industries

Pharmaceutical Products

Words that describe this mark

pharmaceutical preparations prevention treatment central nervous central nervous infections brain diseases central nervous movement disorders ocular motility disorders spinal cord diseases pharmaceutical preparations prevention treatment immunologic diseases autoimmune diseases

Abandonment Notice! On Wednesday, September 24, 2014, status on the FRAIZERON trademark changed to Interruption of proceeding. Apply Now for this name starting at $449!

CAUTION: Although Canada registration for this particular filing is inactive, the mark may still enjoy common law rights, or may have been applied for again in a separate application. Further research may be warranted to determine where this mark is truly abandoned in commerce.

On Tuesday, September 1, 2009, a canadian trademark registration was filed for FRAIZERON by Novartis AG *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1450191. The current status of this trademark filing is Interruption of proceeding. The FRAIZERON trademark is filed in the description of Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations used in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; anti-infectives; antivirals; anti-biotics; systemic and topical anti-fungals. , Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations used in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; anti-infectives; antivirals; anti-biotics; systemic and topical anti-fungals. , Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations used in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; anti-infectives; antivirals; anti-biotics; systemic and topical anti-fungals. .

Get FREE email alerts

100% Satisfaction Guarantee

protect your valuable brand now.

Classification Information

Class Code:	005 - Pharmaceutical Products
Description:	Pharmaceuticals and herbicides

Matter History Events

Status Date	Record Status Description
2014-09-24	Interruption of proceeding - Abandoned - Subsection 40(3)
2014-03-03	National prosecution history entry - Extension of Time
2013-09-03	National prosecution history entry - Extension of Time
2013-03-01	National prosecution history entry - Extension of Time
2012-09-10	National prosecution history entry - Extension of Time
2011-03-11	National prosecution history entry - Allowed
2011-03-11	National prosecution history entry - Allowance Notice Sent
2010-11-24	Application published - Advertised
2010-11-18	Application accepted - Approved
2010-09-27	National prosecution history entry - Approval Notice Sent
2010-07-26	National prosecution history entry - Correspondence Created
2010-01-20	National prosecution history entry - Search Recorded
2010-01-20	National prosecution history entry - Examiner's First Report
2009-09-03	Filing date accorded - Formalized
2009-09-02	National prosecution history entry - Created
2009-09-01	Application filed - Filed

Word Mark:	FRAIZERON
Current Status:	Interruption of proceeding DEAD Mark! Start a New Filing Request 9/24/2014
Application Number:	1450191
Filing Date:	Tuesday, September 1, 2009
Filing Place:	Canada
Registration Date:	Not Available
Register Type:	Primary
Type Of Mark:	Trademark
Mark Feature:	Word
Use In Commerce:	No
Publication Registration:	Wednesday, November 24, 2010
Opposition:	11/24/2010 - 11/24/2010
Last Applicant/Owner:	NOVARTIS AG ******* ****** * **
Correspondent:	Not provided

Goods and Services Information
Description:	(1) - Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations used in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; anti-infectives; antivirals; anti-biotics; systemic and topical anti-fungals. (2) - Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations used in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; anti-infectives; antivirals; anti-biotics; systemic and topical anti-fungals. (3) - Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations used in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; anti-infectives; antivirals; anti-biotics; systemic and topical anti-fungals.

Perfect for these industries

Words that describe this mark

a canadian trademark registration was filed for by . The Canadian IP office has given the trademark application number of . The current status of this trademark filing is . The correspondent listed for is The trademark is filed in the description of .

Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms! You can register your trademark in 180+ countries in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

100% Satisfaction Guarantee

protect your valuable brand now.

How it works

1. Trademarkia Network Law firm - #1 Trademark Filing since 2010.

2. Describe how your business or product is being used. Register your mark in 180+ countries.

What you get

1. Top Global Specialist - Credibility and Experience!

2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK

How it works

1. Trademarkia Network Law firm - #1 Trademark Filing since 2010.

2. Describe how your business or product is being used. Register your mark in 180+ countries.

What you get

1. Top Global Specialist - Credibility and Experience!

2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK

What You Can Do:

Start Your Business

Get FREE email alerts

Add to Favorites

Start Canada Trademark Filing

Custom Logo Design $99

Search on popular social networks

This mark may be available for re-registration. You can apply for it through Trademarkia at a low cost of $449!

Trademarkia.com will perform a final search in order to verify that this mark is available for Canada Trademark re-registration. All Trademarkia services are backed by a 100% satisfaction guarantee.

Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!

As seen on